Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
about
Effect of substrate residues on the P2' preference of retroviral proteinasesAlteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV.Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteasesNew findings in cleavage sites variability across groups, subtypes and recombinants of human immunodeficiency virus type 1A genetic screen for the isolation and characterization of site-specific proteases.Real-time measurements of dark substrate catalysisMolecular mechanisms of FIV infection.Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.The eukaryotic translation initiation factor 4GI is cleaved by different retroviral proteasesApoptosis mediated by HIV protease is preceded by cleavage of Bcl-2Role of darunavir in the management of HIV infection.Comparative studies on retroviral proteases: substrate specificity.Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?Configurations of diastereomeric hydroxyethylene isosteres strongly affect biological activities of a series of specific inhibitors of human-immunodeficiency-virus proteinase.Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity.Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sitesToxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway.Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance.Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase.Conversion of thymidylate synthase into an HIV protease substrate.
P2860
Q28372993-3B9DFAA5-987E-4291-AADD-8F219275B714Q30860360-667C47C2-1C10-45F7-ACFA-4403BBD2A289Q33786404-B41D69D8-2D08-49B0-8E98-90F5FB7CD3C7Q34379398-90B241B9-E522-4D26-BAE0-25BE4DE015C8Q35020110-5697B57B-2DF1-46E5-B04D-0A9D7EECAB76Q35091548-C5613E1F-8F7A-45FB-98FF-F49419D8560FQ35972875-7C253C30-D8A5-4029-9F7A-5E851F92EBF6Q36281355-19EE5B3B-38BE-424A-9399-4C93F2A12E9CQ36692802-0A7B4317-D8DA-4870-AFF1-C5B18377AE63Q36933950-25C9E7FB-1ED0-4532-8C60-863E51370D0CQ37059887-FC0DD5EC-08EF-4887-B8AD-F2F06C528A5FQ37356313-18081404-B2B3-4F60-8008-50DA92A13EA6Q37957871-5B23F11D-82FC-4376-B895-5B4D28FE6854Q38613993-A2A9AAC5-0819-424B-8DB7-7EF0C194BEEFQ39864139-C1DD9BF2-8327-423E-9B30-89C0AC5A5822Q42545682-E1E3EF8D-C4C3-4C32-B5E0-BB4F03AFB184Q42552199-61EE892B-C9D2-47DA-82BB-794761475ADDQ42702065-67B07F99-318B-4854-A9AC-DD2BEEBBEFFEQ42994694-E695EBC4-3F22-49A7-8F67-002C99297FD3Q43994824-54587390-785E-4180-B040-8C4DDA52AF37Q45751051-23206A3D-094E-49C1-B17A-91EC5AD1E828Q54583348-D6C6E189-4BE5-4186-AF00-B83C98896875
P2860
Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Specificity of retroviral prot ...... d nonviral protein substrates.
@en
type
label
Specificity of retroviral prot ...... d nonviral protein substrates.
@en
prefLabel
Specificity of retroviral prot ...... d nonviral protein substrates.
@en
P1476
Specificity of retroviral prot ...... d nonviral protein substrates.
@en
P2093
Heinrikson RL
Tomasselli AG
P304
P356
10.1016/0076-6879(94)41069-0
P407
P577
1994-01-01T00:00:00Z